Autologus hematopoeitic stem cells for the treatment of critical limb ischemia
This study aims to treat critical limb ischemia patients with their own, previously collected, blood stem cells (peripheral HSCs) and to assess improvement in blood flow in the most severely affected leg.
Read More
Product Information for
Autologus hematopoeitic stem cells for the treatment of critical limb ischemia